Methods for treating Metabolic Disorders and obesity with peptides based on assets to the Glucagon Receptor glucose dependent insulinotropic Peptide (GIP) / glucagon like peptide 1 (glp-1)

摘要

Methods for Administration of an endogenous co agonist Peptide glucagon like peptide 1 (glp-1) / glucose dependent insulin Tropic Peptide (GIP) average life extended to a patient who needs to reduce weight gain, induce Weight Loss, treating the hiperglucem Ia, reduce Blood glucose levels,Or to normalize Blood glucose levels in this patient.